(Q35005863)
Statements
1 reference
JAM-A and ALCAM are therapeutic targets to inhibit diapedesis across the BBB of CD14+CD16+ monocytes in HIV-infected individuals (English)
1 reference
Susan Morgello
1 reference
Kathryn Anastos
1 reference
Joan W Berman
1 reference
24 November 2014
1 reference
1 reference
97
1 reference
2
1 reference
401-412
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference